Clinical trials are the most costly, time-consuming, and heavily regulated stages in drug development, often costing hundreds of millions of dollars and sometimes exceeding a billion dollars. Every month of delay cuts into the patent-protected window that determines a drug’s commercial viability, with companies losing tens of millions of dollars